Guanfacine HCl

Trade Name:

Intuniv XR

Manufacturer/Distributor:

Shire Canada

514-787-2300

www.shirecanada.com

Classification:

Alpha adrenergic receptor agonist for ADHD

ATC Class:

C02AC - Imidazoline receptor agonists

Status:

active

Notice of Compliance (yyyy/mm/dd):

2013/07/05

Date Marketed in Canada (yyyy/mm/dd):

2013/08/06

Presentation:

Tablet: 1 mg. DIN: 02409100

Tablet: 2 mg. DIN: 02409119

Tablet: 3 mg. DIN: 02409127

Tablet: 4 mg. DIN: 02409135

Comments:

For treatment or adjunctive therapy of attention deficit disorder with hyperactivity in children aged 6-12 years.

Keywords:

guanfacine

Keywords:

attention deficit disorder with hyperactivity

Access:

public

Back to:

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database

A (37) | B (20) | C (24) | D (37) | E (40) | F (12) | G (11) | H (9) | I (24) | K (1) | L (26) | M (12) | N (7) | O (12) | P (28) | R (14) | S (27) | T (33) | U (4) | V (13) | W (2) | Z (4)

Generic Name	Common Trade Name(s)	Classification	Date Marketed in Canada (yyyy/mm/dd)
Guanfacine HCl	Intuniv XR	Alpha adrenergic receptor agonist for ADHD	2013/08/06
Heparin Sodium	Hepalean	Heparin anticoagulant
Homatropine	Isopto Homatropine	Mydriatic agent
Human Papillomavirus Vaccine	Cervarix	Vaccine	2010/02/05
Hydrocodone + phenylephrine + pyrilamine + ammonium chloride	Hycomine Syrup	Narcotic	2011/05/11
Hydrocodone resin with phenyltoloxamine	Tussionex tablets	Narcotic
Hydromorphone	Dilaudid injection; Dilaudid HP injection	Narcotic
Hydromorphone hydrochloride	Jurnista	opioid anaglesic	2010/04/13
Hydromorphone hydrochloride	Hydromorph Contin	Opioid analgesic	2011/04/01
Hydroxocobalamin	Cyanokit	Antidote	2011/05/24
Ibuprofen	Caldolor	NSAID	2012/05
Ibuprofen & Methocarbamol	Summit Ultra	Muscle relaxant/analgesic	2012/03/14
Imiquimod	Vyloma	Immune response modifier	2011/05/04
Indacaterol + glycopyrronium bromide + mometasone	Enerzair Breezhaler	Asthma medication	2020/11/05
Indacaterol maleate	Onbrez Breezhaler	Long-acting beta 2 agonist	2012/03
Indomethacin	Indomethacin P.D.A.	NSAID	2011/11/15
Infliximab	Avsola	Biological response modifier	2020/06/01
Influenza Vaccine	Intanza	Vaccine	2010/08/01
Influenza Vaccine	Flumist	Vaccine	2010/08/13
Influenza Vaccine	Agriflu	Vaccine	2010/09/01
Influenza vaccine	Fluad	Influenza vaccine	2011/08/25
Insulin aspart + niacinamide	Fiasp	Insulin analogue	2017/04/06
Interferon beta-1b	Extavia	Biologic response modifier	2010/05/17
Ipilimumab	Yervoy	Antineoplastic agent	2012/03
Iron isomaltoside	Monoferric	Iron preparation	2018/06/22
Isatuximab	Sarclisa	Antineoplastic agent, monoclonal antibody	2020/07/03
Isotretinoin	Epuris	Acne therapy	2013-03-14
Ivabradine	Lancora	Cardiac medication	2017/04
Ivacaftor	Kalydeco	Cystic fibrosis transmembrane conductance regulator potentiator	2012/12/01
Ivacaftor + tezacaftor	Symdeko	Cystic Fibrosis Transmembrane Conductance Regulator Correctors and Potentiators	2018/06/27
Ivermectin	Rosiver	Topical rosacea therapy	2015/05/25
Ivermectin	Stromectol	Anthelmintic	2018/11/07
Ixazomib	Ninlaro	Antineoplastic agent	2016/09/21
Ixekizumab	Taltz	Immunomodulator	2018/03/29
Ketorolac tromethamine	Acuvail	Topical NSAID	2011/10/01
Lacosamide	Vimpat	Anticonvulsant	2010/10/21